Immune checkpoint inhibitors (ICIs), a powerful form of immunotherapy, have revolutionized cancer treatment by unleashing the ...

A new research paper was published in Volume 16 of Oncotarget on July 9, 2025, titled "A novel anti-human CD25 mAb with ...

Indian scientists discover cancer drug SB431542 effectively fights COVID-19, showing potential to prevent virus resistance in ...

The most significant recent advances in the application of monoclonal antibodies (mAbs) to oncology have been the introduction and approval of bevacizumab (Avastin), an anti–vascular endothelial ...

SIGLEC 10 identified as a genetic driver for amyloid plaque formation in mice ONC-841 blockade reduced amyloid plaques, normalized microglia function, and improved memory in preclinical Alzheimer’s ...

A new pilot clinical study will explore the safety and effectiveness of 2 anti-canine monoclonal antibodies on solid tumors ...

Immunomodulatory therapeutic monoclonal antibodies that bind immune cells exhibit higher anti-tumor activity when they have a looser grip on immune cell receptors.

Session ID: 2025-07-23:d98251a6f35659ab35b8c63e Player Element ID: vjs_video_3 ...

Recombinant humanized anti-HER2 monoclonal antibody, administered as a single agent, produces durable objective responses and is well tolerated by women with HER2-overexpressing metastatic breast ...